COM:PYXISONCOLOGY

Pyxis Oncology, Inc.

Stock

Last Close

2.10

22/11 21:00

Market Cap

174.31M

Beta: -

Volume Today

4.13M

Avg: -

Overview Analysis Metrics Financials Filings people API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-2.77M -	-12.83M 362.77%	-75.97M 492.26%	-120.72M 58.89%	-73.79M 38.87%
depreciation and amortization		469K -	647K 37.95%	709K 9.58%	1.93M 171.79%
deferred income tax			6.28M -
stock based compensation	28K -	44K 57.14%	6.44M 14,538.64%	15.76M 144.74%	16.95M 7.50%
change in working capital	505K -	2.29M 352.87%	6.68M 191.91%	4.50M 32.58%	-3.51M 177.92%
accounts receivables
inventory
accounts payables	292K -	558K 91.10%	4.64M 732.08%	-8.33M 279.37%	-3.51M 57.89%
other working capital	213K -	1.73M 711.74%	2.03M 17.58%	12.83M 531.04%	3.51M 72.66%
other non cash items		-56K -	20.60M 36,892.86%	10.41M 49.49%	-15.79M 251.73%
net cash provided by operating activities	-2.24M -	-10.08M 350.38%	-35.33M 250.32%	-89.33M 152.89%	-70.71M 20.85%
investments in property plant and equipment		-1.48M -	-540K 63.59%	-6.40M 1,085%	-6.73M 5.11%
acquisitions net			-50K -
purchases of investments			-50K -		-196.83M -
sales maturities of investments			50.05K -
other investing activites			-50 -		98.71M -
net cash used for investing activites		-1.48M -	-590K 60.22%	-6.40M 984.58%	-104.85M 1,538.52%
debt repayment
common stock issued	13K -	35K 169.23%	152.30M 435,031.43%	183K 99.88%	132K 27.87%
common stock repurchased
dividends paid
other financing activites	21.94M -	35 100.00%	151.75M 433,565,614.29%		5.80M -
net cash used provided by financing activities	21.95M -	35K 99.84%	304.04M 868,597.14%	183K 99.94%	5.93M 3,139.89%
effect of forex changes on cash
net change in cash	19.72M -	-11.53M 158.49%	268.13M 2,425.08%	-95.55M 135.64%	-169.63M 77.53%
cash at beginning of period	4K -	19.72M 492,900%	8.19M 58.48%	276.32M 3,274.65%	180.76M 34.58%
cash at end of period	19.72M -	8.19M 58.48%	276.32M 3,274.65%	180.76M 34.58%	11.14M 93.84%
operating cash flow	-2.24M -	-10.08M 350.38%	-35.33M 250.32%	-89.33M 152.89%	-70.71M 20.85%
capital expenditure		-1.48M -	-540K 63.59%	-6.40M 1,085%	-6.73M 5.11%
free cash flow	-2.24M -	-11.57M 416.61%	-35.87M 210.07%	-95.73M 166.92%	-77.44M 19.11%

All numbers in (except ratios and percentages)